Zevra Therapeutics Inc (NASDAQ: ZVRA) – Suitable For Long Term Buy?
Currently, there are 41.49M common shares owned by the public and among those 38.15M shares have been available to trade. Insiders at the company have transacted a total of 25 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 25 of these insider trades were purchases, […]
